We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.29B
1-Year Est. Return 4.86%
This Fund
S&P 500
This Quarter Est. Return
-1.19%
1 Year Est. Return
-4.86%
3 Year Est. Return
+64.44%
5 Year Est. Return
+96.88%
10 Year Est. Return
+353.21%
AUM
$4.26B
AUM Growth
-$118M
Cap. Flow
-$47.9M
Cap. Flow %
-1.12%
Top 10 Hldgs %
73.27%
Holding
299
New
5
Increased
187
Reduced
15
Closed
28

Top Buys

Rank Stock Value
1
CAT icon
Caterpillar
CAT
+$4.87M
2
SCCO icon
Southern Copper
SCCO
+$4.86M
3
OKE icon
Oneok
OKE
+$3.88M
4
MSFT icon
Microsoft
MSFT
+$3.87M
5
EPD icon
Enterprise Products Partners
EPD
+$3.66M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$35.8M
2
LLY icon
Eli Lilly
LLY
+$32.9M
3
IT icon
Gartner
IT
+$18.4M
4
BNTX icon
BioNTech
BNTX
+$2.75M
5
ENTG icon
Entegris
ENTG
+$1.85M

Sector Composition

Rank Sector Weight
1 Healthcare 51.19%
2 Technology 7.33%
3 Energy 7.29%
4 Miscellaneous 5.96%
5 Utilities 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAS icon
76
Masco
MAS
$13.4B
$3.1M 0.07%
43,973
+179
+0.4% +$12.6K
VZ icon
77
Verizon
VZ
$205B
$3.07M 0.07%
69,825
+4,043
+6% +$175K
MLPX icon
78
Global X MLP & Energy Infrastructure ETF
MLPX
$3.54B
$2.89M 0.07%
46,022
+547
+1% +$33.5K
PG icon
79
Procter & Gamble
PG
$342B
$2.83M 0.07%
18,433
+930
+5% +$145K
ACN icon
80
Accenture
ACN
$116B
$2.54M 0.06%
10,301
+60
+0.6% +$15.6K
TPYP icon
81
Tortoise North American Pipeline ETF
TPYP
$862M
$2.51M 0.06%
+68,861
New +$2.44M
ED icon
82
Consolidated Edison
ED
$38.9B
$2.35M 0.06%
23,388
+703
+3% +$70.5K
ACRS icon
83
Aclaris Therapeutics
ACRS
$773M
$2.33M 0.05%
1,225,476
-126,800
-9% -$221K
HD icon
84
Home Depot
HD
$303B
$2.25M 0.05%
5,566
+10
+0.2% +$3.93K
DKNG icon
85
DraftKings
DKNG
$11.9B
$2.22M 0.05%
59,417
AMLP icon
86
Alerian MLP ETF
AMLP
$13.3B
$2.19M 0.05%
46,698
-971
-2% -$47K
JCI icon
87
Johnson Controls International
JCI
$84.5B
$2.16M 0.05%
19,629
+59
+0.3% +$6.3K
PAYX icon
88
Paychex
PAYX
$41.5B
$2.09M 0.05%
16,496
+100
+0.6% +$13.9K
LMT icon
89
Lockheed Martin
LMT
$123B
$2.06M 0.05%
4,121
PRME icon
90
Prime Medicine
PRME
$537M
$2M 0.05%
361,136
CLX icon
91
Clorox
CLX
$10.3B
$1.99M 0.05%
16,129
+895
+6% +$111K
MDLZ icon
92
Mondelez International
MDLZ
$79.7B
$1.97M 0.05%
31,458
+220
+0.7% +$14.2K
MTCH icon
93
Match Group
MTCH
$10B
$1.94M 0.05%
54,875
+317
+0.6% +$11.3K
SHEL icon
94
Shell
SHEL
$273B
$1.8M 0.04%
25,124
+805
+3% +$58K
NEE icon
95
NextEra Energy
NEE
$167B
$1.75M 0.04%
23,226
+785
+3% +$57.4K
NGG icon
96
National Grid
NGG
$76.4B
$1.71M 0.04%
23,883
+1,509
+7% +$106K
BKH icon
97
Black Hills Corp
BKH
$5.35B
$1.7M 0.04%
27,645
+698
+3% +$41.1K
CVS icon
98
CVS Health
CVS
$117B
$1.69M 0.04%
22,421
+230
+1% +$15.8K
ES icon
99
Eversource Energy
ES
$25.5B
$1.61M 0.04%
22,675
+1,199
+6% +$78.6K
RIO icon
100
Rio Tinto
RIO
$155B
$1.33M 0.03%
20,201
-2,081
-9% -$129K

Similar funds

Bollard Group's Q3 2025 Portfolio in Review

As of Q3 2025, Bollard Group held 299 positions worth $4.26B, down 2.7% from $4.37B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Bollard Group's Q3 2025 filing shows 5 new, 187 increased, 15 reduced and 28 closed positions. Its largest new stake was Tortoise North American Pipeline ETF: 68,861 shares worth $2.51M. The largest sale was Boston Scientific, an estimated $35.8M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 56% a quarter earlier, followed by Technology and Energy.

  • Bollard Group's largest Q3 2025 buy was Tortoise North American Pipeline ETF: 68,861 shares worth $2.51M.
  • Bollard Group added most to Caterpillar in Q3 2025, an estimated $4.87M increase.
  • Bollard Group's biggest Q3 2025 reduction was Boston Scientific, cutting an estimated $35.8M.
  • Bollard Group fully exited BioNTech in Q3 2025, selling an estimated $2.75M.
  • Bollard Group's ten largest holdings make up 73% of its $4.26B portfolio in Q3 2025.
  • Bollard Group opened 5 new positions and closed 28 in Q3 2025.
  • Bollard Group's portfolio value fell 2.7% quarter-over-quarter to $4.26B.

Based on Bollard Group's 13F filing for Q3 2025, filed 14 Nov 2025.